NEW YORK (Reuters Health) – The addition of bevacizumab (Avastin; Genentech/Roche) to the standard docetaxel and prednisone in men with progressive metastatic castration-resistant prostate cancer (mCRPC) did not…
NEW YORK (Reuters Health) – Antibiotic therapy in the first week of acute mild to moderate sinusitis is not worth it and should be avoided, conclude the authors…
NEW YORK (Reuters Health) – Goiter should be considered in the differential diagnosis of positional dyspnea, even in patients without obvious thyroid enlargement, according to a new retrospective…
NEW YORK (Reuters Health) – A sirolimus-eluting stent (SES) was superior to a bare-metal stent (BMS) in a group of unselected patients who had primary percutaneous coronary intervention…
NEW YORK (Reuters Health) – Administration of an erythropoiesis-stimulating agent or ESA (in this case, darbepoietin) to patients with severe traumatic brain injury (STBI) improves survival without increasing…
NEW YORK (Reuter Health) – Results of a meta-analysis indicate that outcomes related to recovery are equivalent or superior with intracapsular tonsillectomy as compared with total tonsillectomy in…
NEW YORK (Reuters Health) – For treatment of femoropopliteal artery disease, angioplasty using a paclitaxel-eluting balloon (PEB) is associated with a high sustained patency rate and a low…
NEW YORK (Reuters Health) – Results of a meta-analysis indicate that patients with chronic kidney disease (CKD) derive little net benefit from antiplatelet therapy in terms of cardiovascular…
NEW YORK (Reuters Health) – Golimumab, a new anti-TNF monoclonal antibody, administered subcutaneously every 4 weeks, shows sustained efficacy in reducing signs and symptoms of active psoriatic arthritis…
NEW YORK (Reuters Health) – Intraoperative hypothermia to less than 35 C more than doubles the risk of surgical site infections after trauma laparotomy, according to a report…
